trending Market Intelligence /marketintelligence/en/news-insights/trending/U-ugGCfnXLdT1_1bOnTEIw2 content esgSubNav
In This List

ContraVir Pharmaceuticals chief medical officer steps down

Blog

Insight Weekly: M&A outlook; US community bank margins; green hydrogen players' EU expansion

Blog

Global M&A by the Numbers: Q2 2022

Blog

Insight Weekly: US bank M&A; low refinancing eases rates impact; Texas crypto mining booms

Blog

Infographic 2022 Top Tech Trends Shaping Corporations


ContraVir Pharmaceuticals chief medical officer steps down

ContraVir Pharmaceuticals Inc. said John Sullivan-Bolyai is stepping down as chief medical officer and taking on a new role in the company, effective Dec. 29.

Sullivan-Bolyai will serve as a part-time consultant to the company, where he will remain involved in strategic decisions as well as medical and clinical affairs.